Transforming the genome to drug discovery
- 28 May 2002
- journal article
- editorial
- Published by Elsevier in Drug Discovery Today
- Vol. 7 (11) , 583-584
- https://doi.org/10.1016/s1359-6446(02)02267-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Chemogenomic approaches to drug discoveryCurrent Opinion in Chemical Biology, 2001
- Forecasting Roles of Combinatorial Chemistry in the Age of Genomically Derived Drug Discovery TargetsCombinatorial Chemistry & High Throughput Screening, 2000
- Journey to the Center of BiologyScience, 2000
- Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic eraChemistry & Biology, 1999
- A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinaseProtein Science, 1998
- Molecular Basis for p38 Protein Kinase Inhibitor SpecificityBiochemistry, 1998
- Acquisition of Sensitivity of Stress-activated Protein Kinases to the p38 Inhibitor, SB 203580, by Alteration of One or More Amino Acids within the ATP Binding PocketPublished by Elsevier ,1998
- Drug Development: The role of innovation in drug developmentNature Biotechnology, 1997
- The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinaseChemistry & Biology, 1997